BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 34122405)

  • 1. The Diagnostic and Prognostic Potential of the B-Cell Repertoire in Membranous Nephropathy.
    Su Z; Jin Y; Zhang Y; Guan Z; Li H; Chen X; Xie C; Zhang C; Liu X; Li P; Ye P; Zhang L; Kong Y; Luo W
    Front Immunol; 2021; 12():635326. PubMed ID: 34122405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Landscape and Prognosis Potential of the T-Cell Repertoire in Membranous Nephropathy.
    Zhang Y; Jin Y; Guan Z; Li H; Su Z; Xie C; Chen X; Liu X; Pan Y; Ye P; Zhang L; Kong Y; Luo W
    Front Immunol; 2020; 11():387. PubMed ID: 32210970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The landscape and diagnostic potential of T and B cell repertoire in Immunoglobulin A Nephropathy.
    Huang C; Li X; Wu J; Zhang W; Sun S; Lin L; Wang X; Li H; Wu X; Zhang P; Xu G; Wang H; Liu H; Liu Y; Chen D; Zhuo L; Li W; Yang H; Wang J; Wang L; Liu X
    J Autoimmun; 2019 Feb; 97():100-107. PubMed ID: 30385082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noninvasive diagnosis of primary membranous nephropathy using phospholipase A2 receptor antibodies.
    Bobart SA; De Vriese AS; Pawar AS; Zand L; Sethi S; Giesen C; Lieske JC; Fervenza FC
    Kidney Int; 2019 Feb; 95(2):429-438. PubMed ID: 30665573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating antibodies to α-enolase and phospholipase A
    Kimura Y; Miura N; Debiec H; Morita H; Yamada H; Banno S; Ronco P; Imai H
    Clin Exp Nephrol; 2017 Feb; 21(1):117-126. PubMed ID: 26830547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of PLA2R Autoantibodies before the Diagnosis of Membranous Nephropathy.
    Burbelo PD; Joshi M; Chaturvedi A; Little DJ; Thurlow JS; Waldman M; Olson SW
    J Am Soc Nephrol; 2020 Jan; 31(1):208-217. PubMed ID: 31843984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoglobulin somatic hypermutation has clinical impact in DLBCL and potential implications for immune checkpoint blockade and neoantigen-based immunotherapies.
    Xu-Monette ZY; Li J; Xia Y; Crossley B; Bremel RD; Miao Y; Xiao M; Snyder T; Manyam GC; Tan X; Zhang H; Visco C; Tzankov A; Dybkaer K; Bhagat G; Tam W; You H; Hsi ED; van Krieken JH; Huh J; Ponzoni M; Ferreri AJM; Møller MB; Piris MA; Winter JN; Medeiros JT; Xu B; Li Y; Kirsch I; Young KH
    J Immunother Cancer; 2019 Oct; 7(1):272. PubMed ID: 31640780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence, diagnostic value and clinical characteristics associated with the presence of circulating levels and renal deposits of antibodies against the M-type phospholipase A2 receptor in idiopathic membranous nephropathy.
    Segarra-Medrano A; Jatem-Escalante E; Quiles-Pérez MT; Salcedo MT; Arbós-Via MA; Ostos H; Valtierra N; Carnicer-Cáceres C; Agraz-Pamplona I
    Nefrologia; 2014 May; 34(3):353-9. PubMed ID: 24798555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kidney biopsy is a sensitive tool for retrospective diagnosis of PLA2R-related membranous nephropathy.
    Svobodova B; Honsova E; Ronco P; Tesar V; Debiec H
    Nephrol Dial Transplant; 2013 Jul; 28(7):1839-44. PubMed ID: 23223223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-Phospholipase A2 Receptor (Anti-PLA2R) Antibody in Diagnosis and Treatment of Idiopathic Membranous Nephropathy: A Single-Center Observational Study in China.
    Guo N; Cao Y; Dai H; Yuan L; Shi L; Zhang Y
    Med Sci Monit; 2019 Dec; 25():9364-9368. PubMed ID: 31813930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarker prediction for membranous nephropathy prognosis by microarray analysis.
    Zhou G; Xin G; Zhang W; Zhang X
    Nephrology (Carlton); 2019 May; 24(5):526-533. PubMed ID: 30084529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrasensitive Quantitation of Anti-Phospholipase A2 Receptor Antibody as A Diagnostic and Prognostic Indicator of Idiopathic Membranous Nephropathy.
    Zhang Q; Huang B; Liu X; Liu B; Zhang Y; Zhang Z; Hua J; Fan Y; Hu L; Meng M; Wu M; Wang L; Hu Z; Sun Z
    Sci Rep; 2017 Sep; 7(1):12049. PubMed ID: 28935926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and pathological analysis of hepatitis B virus-related membranous nephropathy and idiopathic membranous nephropathy.
    Li P; Wei RB; Tang L; Wu J; Zhang XG; Chen XM
    Clin Nephrol; 2012 Dec; 78(6):456-64. PubMed ID: 23164414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-PLA2R-associated membranous nephropathy: a review with emphasis on diagnostic testing methods.
    VanBeek C; Haas M
    Clin Nephrol; 2015 Jul; 84(1):1-9. PubMed ID: 25997506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Membranous nephropathy with crescents: a series of 19 cases.
    Rodriguez EF; Nasr SH; Larsen CP; Sethi S; Fidler ME; Cornell LD
    Am J Kidney Dis; 2014 Jul; 64(1):66-73. PubMed ID: 24709471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy.
    Hoxha E; Kneißler U; Stege G; Zahner G; Thiele I; Panzer U; Harendza S; Helmchen UM; Stahl RA
    Kidney Int; 2012 Oct; 82(7):797-804. PubMed ID: 22673885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-throughput sequencing analysis of genes encoding the B-lymphocyte receptor heavy-chain CDR3 in renal and peripheral blood of IgA nephropathy.
    Chen D; Zhang Z; Yang Y; Hong Q; Li W; Zhuo L
    Biosci Rep; 2019 Oct; 39(10):. PubMed ID: 31551340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B Cells in Primary Membranous Nephropathy: Escape from Immune Tolerance and Implications for Patient Management.
    So BYF; Yap DYH; Chan TM
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical features, course and prognosis of idiopathic membranous nephropathy depending on the presence of antibodies against M-type phospholipase A2 receptor.
    Jatem Escalante E; Segarra Medrano A; Carnicer Cáceres C; Martín-Gómez MA; Salcedo Allende MT; Ostos Roldan H; Agraz Pamplona I
    Nefrologia; 2015; 35(5):479-86. PubMed ID: 26306972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Geographic patterns and pathogenetic implications of IGHV gene usage in chronic lymphocytic leukemia: the lesson of the IGHV3-21 gene.
    Ghia P; Stamatopoulos K; Belessi C; Moreno C; Stella S; Guida G; Michel A; Crespo M; Laoutaris N; Montserrat E; Anagnostopoulos A; Dighiero G; Fassas A; Caligaris-Cappio F; Davi F
    Blood; 2005 Feb; 105(4):1678-85. PubMed ID: 15466924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.